New Delhi: Blood drawing for test has really reached proverbial ant bite, thanks to introduction of innovative blood collection technology by Metropolis healthcare, India’s second largest pathology laboratory chain. First of kind technology named UltraTouch™ Push Button Blood Collection Set (PBBCS) minimizes pain and, in turn, needle anxiety. Pain in the process may be overrated but, despite ant bite assurance, most people flinch when needle pierces. For lot of people even thought of it is traumatic.
So far as pain during piercing of needle to draw blood is concerned, Ameera Shah-led Metropolis Healthcare Limited has become a cut above the rest due to this new technology. This will for sure improve patient experience of the process across its service network. This state-of-the-art device features a thinner needle that reduces insertion pain and makes blood collection more comfortable for first-time patients, children, and the elderly. Aligned with Metropolis’ mission to improve patient care, this innovative approach aims to make the blood collection process quicker, safer, and less cumbersome for people of all ages.
Surendran Chemmenkotil, Chief Executive Officer says, ‘The UltraTouch™ PBBCS represents a significant advancement in patient comfort and safety during blood collection, while also ensuring the accuracy of our results. By leveraging this cutting-edge technology, we are addressing gaps in diagnostics to enhance the overall patient experience.”
Blood tests are crucial for over 70 per cent of medical decisions; however, many patients hesitate due to concerns about pain. Even studies indicate that nearly 80 percent of patients believe their blood draw experience significantly impacts their overall satisfaction with healthcare providers.
A recent study published in the Journal of Evolution of Medical and Dental Sciences (JEMDS) evaluated the impact of the UltraTouch™ PBBCS at Metropolis Healthcare’s Global Reference Laboratory in Mumbai over a one-month period. Over 90% of participants reported minimal discomfort with no signs of hemolysis, leading to an improved overall experience. The laboratory parameters of potassium, iron, and haemoglobin levels also remained consistent. This assessment involved a diverse group of adult participants, focusing on the device’s effectiveness in reducing pain and ensuring the reliability of blood samples and needle injuries.
Kannan Alangadan, Chief Operating Officer, said, ‘As someone deeply involved in patient care, I understand the anxiety that often accompanies with blood collection, At Metropolis, our focus is on elevating the patient experience through innovative technology and compassionate care. Our dedicated phlebotomists and technicians are committed to delivering exceptional service across our network. With a leading Net Promoter Score of 87, we continually prioritize patient comfort and satisfaction in every interaction.’
In addition to prioritizing patient comfort, the innovative blood collection system is designed to improve efficiency within laboratories. By reducing the time required for blood draws and minimizing the risk of complications, Metropolis Healthcare can ensure faster turnaround times for test results, ultimately benefiting patient care.
%20is%20transforming%20Biomedical%20&%20Medical%20Device%20Workforce%20Scenario){kind=link}